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Abstract: Ocellatins are peptides produced in the skins of frogs belonging to the genus Leptodactylus
that generally display weak antimicrobial activity against Gram-negative bacteria only. Peptidomic
analysis of norepinephrine-stimulated skin secretions from Leptodactylus insularum Barbour 1906 and
Leptodactylus nesiotus Heyer 1994, collected in the Icacos Peninsula, Trinidad, led to the purification and
structural characterization of five ocellatin-related peptides from L. insularum (ocellatin-1I together
with its (1–16) fragment, ocellatin-2I and its (1–16) fragment, and ocellatin-3I) and four ocellatins from
L. nesiotus (ocellatin-1N, -2N, -3N, and -4N). While ocellatins-1I, -2I, and -1N showed a typically low
antimicrobial potency against Gram-negative bacteria, ocellatin-3N (GIFDVLKNLAKGVITSLAS.NH2)
was active against an antibiotic-resistant strain of Klebsiella pneumoniae and reference strains of
Escherichia coli, K. pneumoniae, Pseudomonas aeruginosa, and Salmonella typhimurium (minimum
inhibitory concentrations (MICs) in the range 31.25–62.5 µM), and was the only peptide active against
Gram-positive Staphylococcus aureus (MIC = 31.25 µM) and Enterococcus faecium (MIC = 62.5 µM).
The therapeutic potential of ocellatin-3N is limited by its moderate hemolytic activity (LC50 = 98 µM)
against mouse erythrocytes. The peptide represents a template for the design of long-acting, non-toxic,
and broad-spectrum antimicrobial agents for targeting multidrug-resistant pathogens.
Keywords: antibiotic resistance; antimicrobial peptides; frog skin secretions; hemolysis; Leptodactylus;
norepinephrine stimulation; ocellatins; peptidomic analysis; phylogenetics; Trinidad
1. Introduction
In an ongoing effort to address the global problem of antimicrobial resistance (AMR) and to
promote the research and development of new antibiotics against emerging multidrug-resistant
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Antibiotics 2020, 9, 718 2 of 15
bacteria, in 2017, the World Health Organization published a list of “priority pathogens” that
cause increased morbidity and mortality and greatly impact healthcare costs [1]. Infections caused
by antibiotic-resistant Gram-negative pathogens, such as extended-spectrum β-lactamase (ESBL)
Escherichia coli and multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella
pneumoniae, are of particular concern because the currently available treatment options are often
ineffective and there are only a few antimicrobial drugs in the pipeline [2]. In order to address this
crisis, the AMR Action Fund, encompassing more than 20 leading biopharmaceutical companies,
was launched in July 2020, with the aim of bringing at least four new treatments to patients by 2030 [3].
AMR has been described as “a slow tsunami that threatens to undo a century of medical progress” [4].
Consequently, there is clearly a need to identify and develop new kinds of antimicrobial drugs with
acceptable toxicological and pharmacokinetic properties that may be used to treat infections caused by
multidrug-resistant pathogenic microorganisms. Anti-infective compounds based upon peptides are
one such alternative to conventional antibiotics due to their rapid and non-specific mode of action, as
well as their abilities to inhibit biofilm formation and act synergistically with established antibiotics [5].
Several frog species produce peptides with broad-spectrum antibacterial and antifungal activities
that are also able to disrupt the plasma membrane of mammalian cells and more than 1000 such
peptides have been described (reviewed in [6–11]). Although their precise biological role is incompletely
understood, these peptides probably function as a component of the animal’s system of innate immunity,
playing a role in the first-line defense against invading pathogens [12,13]. As peptides from different
frog species may contain regions of structural similarity, they can be grouped into families for the
purpose of classification. In addition, several of these peptides stimulate the production of pro- or
anti-inflammatory cytokines by macrophages, inhibit viral replication, exert cytotoxicity towards
cancer cells, and stimulate insulin release [14]. Consequently, it is more informative to refer to them as
host-defence peptides (HDPs) than exclusively as antimicrobial peptides. Typically, each frog species
has a “finger-print” arsenal of HDPs belonging to different families, whose primary structures can
be used as a tool for elucidating the evolutionary history and complex phylogenetic relations of the
different frog genera [15–17].
The genus Leptodactylus, or nest-building frogs, currently contains 78 species distributed from
southern North America to central South America, including the West Indies [18]. Several frogs
belonging to this genus have been shown to release structurally-related HDPs with antimicrobial
activity into their skin secretions: Leptodactylus ocellatus [19–21], Leptodactylus fallax [22], Leptodactylus
pentadactylus [23,24], Leptodactylus laticeps [25,26], Leptodactylus syphax [27], Leptodactylus validus [28],
Leptodactylus labyrinthicus [29,30], Leptodactylus pustulatus [31], Leptodactylus latrans [32], and
Leptodactylus vastus [33]. These peptides were initially named after the frog species from which
they were first isolated, but they are now classified as ocellatins according to a generally accepted
nomenclature [34]. In addition to the ocellatins, conformationally flexible glycine/leucine-rich plasticins,
which lack antimicrobial activity, have been isolated from the skin secretions of L. pentadactylus [24]
and L. laticeps [26].
As part of a program of investigation to systematically examine the frog species of Trinidad and
Tobago for the presence of dermal biologically-active HDPs, this study involves an investigation of two
Leptodactylus species that have not been studied previously: Leptodactylus insularum Barbour 1906 and
Leptodactylus nesiotus Heyer 1994. The San Miguel Island frog L. insularum (also known as Barbour’s
Thin-Toed frog) is a medium to large frog (snout-vent-length (SVL) for sub-adults/adults is in the range
of 51–83 mm). Previously classified as L. pentadactylus and Leptodactylus bolivianus [35], L. insularum is
found from Costa Rica to Trinidad, but it has not been recorded in Tobago. In Trinidad, this species has
been found at low elevations in the central and southeast parts of the island. The preferred habitats of
the frog include forested areas and swamp margins. Because of its wide distribution range, tolerance
of varied habitats, and presumably large populations, L. insularum is classified by the International
Union for Conservation and Nature (IUNC) Red List of Threatened Species as a species of Least
Concern. The Trinidad Thin-Toed frog L. nesiotus is a small terrestrial frog (adult males SVL 33 mm
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and sub-adults SVL 21–28 mm). This species was considered to be endemic to Trinidad until Jairam
and Fouquet [36] reported, for the first time, its presence on the South American continent in Guyana,
Suriname, and French Guiana. L. nesiotus can be found inhabiting open and swampy areas of the
Icacos Peninsula, as well as many scattered locations in southern Trinidad [35]. L. nesiotus is listed as a
Vulnerable Species by the IUCN.
Both frog species investigated in this study were identified on the basis of their audio calls and
characteristic morphologym as described by Murphy et al. [35]. An injection of norepinephrine was
used to stimulate the release of HDPs into skin secretions, which were purified and characterized by
reversed-phase HPLC in combination with MALDI-TOF mass spectrometry and automated Edman
degradation. The peptides isolated from L. insularum are denoted by I and those isolated from
L. nesiotus by N. Peptides from paralogous genes are differentiated by numerals, e.g., ocellatin-1N and
ocellatin-2N. The antimicrobial potencies of synthetic replicates of four of the ocellatins against a range
of Gram-positive and Gram-negative reference bacteria, including antibiotic-resistant strains, as well
as their cytotoxic activities against mouse erythrocytes, were determined. Additionally, the amino acid
sequences of the peptides were used in cladistic analyses to gain insight into phylogenetic relationships
among the Leptodactylus species studied to-date.
2. Results
2.1. Purification of the Peptides from L. insularum
The pooled skin secretions from L. insularum frogs were initially concentrated by passage through
Sep-Pak C-18 cartridges, followed by chromatography on a Vydac C-18 semipreparative reversed-phase
HPLC column (Figure 1). Further purification to near homogeneity of the peptides at the prominent
peaks (1–5) was achieved by successive chromatographies on semipreparative Vydac C-4 and Vydac
dimethylphenyl columns (chromatograms not shown). Subsequent structural analysis revealed that
peak 1 contained the 1–16 fragment of ocellatin-1I (ocellatin-1I (1–16)), peak 2 the 1-16 fragment
of ocellatin-2I (ocellatin-2I (1–16)), peak 3 ocellatin-1I, peak 4 ocellatin-2I, and peak 5 ocellatin-3I.
All peptides used in the antimicrobial assays displayed a symmetrical peak shape and their purity was
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2.2. Purification of the Peptides from L. nesiotus
The pooled skin secretions from L. nesiotus were subjected to the same chromatographic procedures
used to purify peptides from L. insularum. The elution profile on a Vydac C-18 semipreparative column
is shown in Figure 2 and the peptides of major abundance at peaks 1–4 were collected. Subsequent
structural analysis revealed that peak 1 contained ocellatin-1N, peak 2 ocellatin-2N, and peak 3 and 4
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The amino acid sequences of the ocellatins isolated from L. insularum and L. nesiotus skin secretions
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L. insularum    [M + H]obs  [M + H]calc 
Ocellatin-1I (1-16) GLLDLLKGAGKGLLTH 1606.0 1606.0 
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Ocellatin-3I GVIDILKSLGKNILTNLASKLSDNTA 2698.5 2698.6 
L. nesiotus     
Ocellatin-1N GAVVDILKGAGKNLLSLALNKLSEKVa 2649.3 2649.6 
Ocellatin-2N GAVVDILKDTGKNLLSLALNKLSEKVa 2737.3 2737.6 
Ocellatin-3N GIFDVLKNLAKGVITSLASa 1945.1 1945.3 
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three amino acid residues (positions 5, 6, and 12). In addition, (1-16) fragments of both ocellatin-1I
and -2I were purified from the L. insularum secretions. Ocellatin-1N and -2N differ by two amino
acid residues at positions 9 and 10, whereas ocellatin-3N and -4N differ only by the substitution of
Ile by Leu at position 2. The physicochemical properties of the ocellatin-related peptides isolated in
this study are shown in Table 1. The Grand Average of Hydropathy (GRAVY) was determined using
the hydrophobicity scales of Kyte and Doolittle [37]. The presence of helical domains in the peptides
was predicted using the AGADIR program [38]. The isoelectric point (pI) was calculated using the
following web-site: http://www.bachem.com/service-support/peptide-calculator/.
Table 1. Physicochemical properties of the ocellatin-related peptides isolated in this study from
norepinephrine-stimulated skin secretions of L. insularum and L. nesiotus.
Peptide No. ofAmino Acids
Charge
at pH 7 pI GRAVY
Alpha-Helical
Domain *
Ocellatin-1I (1–16) 16 +1 9.9 0.488 2–9
Ocellatin-2I (1–16) 16 0 7.8 0.169 none
Ocellatin-1I 21 +2 10.6 0.648 2–9, 13–19
Ocellatin-2I 21 +1 9.9 0.405 11–19
Ocellatin-3I 26 +1 9.8 0.205 2–10, 13–21
Ocellatin-1N 26 +3 10.6 0.496 3–10, 12–24
Ocellatin-2N 26 +2 10.2 0.281 12–24
Ocellatin-3N 19 +2 10.2 0.911 4–11, 13–18
Ocellatin-4N 19 +2 10.2 0.874 2–11, 13–18
* Calculations of helicity using the AGADIR program were performed at pH 7, ionic strength 0.1 M, and 278 K.
2.4. Antimicrobial and Hemolytic Activities
The minimum inhibitory concentration (MIC) values for synthetic ocellatin-1I and -2I and
ocellatin-1N and -3N against strains of Gram-positive bacteria Staphylococcus aureus, Enterococcus
faecium, and Enterococcus faecalis and Gram-negative bacteria Escherichia coli, Klebsiella pneumoniae,
Pseudomonas aeruginosa, and Salmonella typhimurium, as well as ampicillin-resistant S. aureus and
antibiotic-resistant K. pneumoniae, are shown in Table 2. Ocellatin-1I, -2I, and -1N exhibited relatively
weak antimicrobial activities (MICs in the range of 62.5–250 µM) against the Gram-negative bacteria
only. Ocellatin-3N from L. nesiotus displayed the greatest activity against all Gram-positive and
Gram-negative microorganisms tested, including the multidrug-resistant strains (MICs in the range of
31.25–62.5 µM). However, this peptide was 4–8 times less potent against the Gram-positive bacterium
E. faecalis (MIC = 250 µM).
Antibiotic sensitivities towards ampicillin (AMP), vancomycin (VAN), and ciprofloxacin (CIP) of
all bacterial strains used were determined prior to setting up the experiments so that an appropriate
control could be used in parallel with incubation with the peptides. The MICs for the antibiotics were
as follows: E. faecalis AMP 4 µg/mL (VAN 64 µg/mL and CIP > 64 µg/mL); E. coli AMP 6.25 µg/mL;
K. pneumoniae CIP 0.13 µg/mL; P. aeruginosa CIP 0.25 µg/mL (AMP 512 µg/mL and VAN > 512 µg/mL);
S. typhimurium CIP 0.13 µg/mL; and S. aureus (ATCC BAA-2312) VAN 2 µg/mL and AMP 16 µg/mL. The
antibiotic-resistant K. pneumoniae strain (ATCC BAA-2814) was not responsive to any of the antibiotics
tested in concentrations ≤ 512 µg/mL. Similarly, E. faecium (ATCC 19434) was not inhibited by either
AMP or VAN in concentrations ≤ 512 µg/mL, as well as by CIP ≤ 64 µg/mL. The S. aureus strain (ATCC
12600) showed a high resistance to AMP (MIC = 100 µg/mL), but was sensitive to VAN (MIC = 2 µg/mL).
When tested for cytotoxicity against mouse erythrocytes in vitro, both ocellatin-1I and -2I were
weakly hemolytic (LC50 > 250 µg/mL). Ocellatin-1N was non-hemolytic (LC50 > 500 µg/mL), whereas
ocellatin-3N was the most cytotoxic (LC50 = 210 µg/mL, equivalent to 98 µM) out of the four
peptides tested.
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Table 2. Minimum inhibitory concentrations in µM (µg/mL) of synthetic replicates of ocellatins isolated
from skin secretions of L. insularum and L. nesiotus against reference and antibiotic-resistant strains of
Gram-positive and Gram-negative bacteria.
Bacteria Ocellatin-1I Ocellatin-2I Ocellatin-1N Ocellatin-3N
Gram-positive
S. aureus (ATCC 12600) 250 (575) >250 (>620) 250 (725) 31.25 (67)
S. aureus (ATCC BAA-2312) 250 (575) >250 (>620) 250 (725) 31.25 (67)
E. faecium (ATCC 19434) n.d. 250 (620) 250 (725) 62.5 (134)
E. faecalis (ATCC 51299) >250 (>575) >250 (>620) >250 (>725) 250 (535)
Gram-negative
E. coli (ATCC 35218) 62.5 (144) 62.5 (155) 62.5 (181) 31.25 (67)
K. pneumoniae (ATCC 49472) 125 (288) 125 (310) 125 (362) 62.5 (134)
K. pneumoniae (ATCC BAA-2814) * >125 (>288) 125 (310) 125 (362) 62.5 (134)
P. aeruginosa (ATCC 27853) n.d. >125 (>310) >125 (>362) 62.5 (134)
S. typhimurium (ATCC 14028) 250 (575) 125 (310) 250 (725) 62.5 (134)
n.d., not determined. * denotes an antibiotic-resistant strain.
2.5. Cladistic Analysis
Figure 4 shows the primary structures of 27 ocellatins isolated from 10 Leptodactylus species.
These amino acid sequences were used to construct the optimal phylogenetic tree shown in Figure 5.
It can be seen that evolutionary pressure was added, primarily to conserve the charged residues
(Lys and Asp) in this family of peptides. The tree was drawn to scale, with branch lengths being given
in the same units as those of the evolutionary distances used to infer the phylogenetic tree.Antibiotics 2020, 9, x FOR PEER REVIEW 7 of 15 
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Figure 5. phylogenetic tree generated using the neighbor-joining ethod with Poisson correction
based upon the pri ary structures of the ocellatin peptides isolated fro frogs belonging to the genus
Leptodactylus that are shown in Figure 4.
3. Discussion
This study has described the purification of five peptides from norepinephrine-stimulated skin
secretions of L. insularum and four peptides from skin secretions of L. nesiotus. Determination of
the primary structures of the peptides revealed that they represent orthologues of the ocellatin frog
skin peptides named after the first member to be identified from a skin secretion of L. ocellatus [19].
The peptidomic approach (reversed-phase HPLC combined with MALDI-TOF mass spectrometry
and automated Edman degradation) allowed the characterization of all of the peptides that were
present in major abundance in the secretions. The advantage of the peptidomic approach is that those
peptides with low or no antimicrobial activity would have been easily missed if the more traditional
bioassay-guided method was utilized for identification of the HDPs [9].
Skin secretions of L. insularum contained two truncated (1–16) fragments of ocellatin-1I and -2I
(Figure 3). The samples from this species were collected, handled, and processed in the author’s
laboratory at the same time as those from L. nesiotus, but no such fragments were detected in the
secretions from the latter. The presence of shorter ocellatin-related peptides appears to be a common
feature for many of the Leptodactylus frogs studied to-date, irrespective of the method used for collection
of the secretions [20,22,28,29]. It is unclear whether the ocellatin fragments originate from the proteolytic
processing of full-length ocellatins by the peptidases that are present in skin secretions or are products
of different genes.
Frog skin HDPs are associated with extreme structural hypervariability and several studies
(reviewed in [15]) have shown that comparisons of their amino acid sequences have proved to be of
value in elucidating the evolutionary history and phylogenetic relationships of frogs within a particular
genus. Such analyses can be used in conjunction with those based upon comparisons of nucleotide
sequences of orthologous genes and morphological criteria. Cladistic analysis based upon the primary
structures of the ocellatins from Leptodactylus frogs supports the conclusion based upon morphological
Antibiotics 2020, 9, 718 8 of 15
criteria [18] that L. nesiotus and L. validus are closely related phylogenetically, whereas L. insularum is
most closely related to L. ocellatus.
It is well-documented that most of the ocellatins isolated to-date show low hemolytic activity and
display only weak antimicrobial activity targeting preferentially Gram-negative bacteria [21,22,24,26,32].
However, ocellatin 4, isolated from L. ocellatus, displayed broad-spectrum antimicrobial activity
by inhibiting both E. coli and S. aureus (MICs = 64 µM) [20] and it was also strongly hemolytic
(LC50 = 14.3 µM). Ocellatin-related fragments may contribute to the general protection exerted by the
full-length peptides, as some of them have been documented to possess various degrees of antimicrobial
and hemolytic activities [27,33]. The in vitro antimicrobial and hemolytic activities of synthetic replicates
of the ocellatins -1I, -2I, -1N, and -3N (selected on the basis of their higher hydrophobicities) were
investigated using a range of reference bacteria, including drug-resistant bacterial strains, and mouse
erythrocytes (Table 2). Ocellatin-3N isolated from skin secretions of L. nesiotus was the only peptide
that displayed broad-spectrum antimicrobial activity (MICs = 31.25–62.5 µM) against Gram-positive
and Gram-negative bacteria, including drug-resistant strains. The hemolytic activity of ocellatin-3N
(LC50 = 98µM) was appreciably greater than the corresponding activities of fallaxin (LC50 > 200µM) [22],
pentadactylin (LC50 > 400 µM) [23], and laticeptin (LC50 > 400 µM) [25]. However, the peptide, while
displaying comparable activity against a range of Gram-positive and Gram-negative bacteria to that of
ocellatin 4 [20], was nearly seven-fold less hemolytic. The cytotoxicity of ocellatin-3N against cell lines
derived from human tissues, such as A549 alveolar basal epithelial cells and HUVEC umbilical vein
endothelial cells, will be addressed in future studies. In addition, the activity of the peptide against
reference strains and clinical isolates of opportunist yeast pathogens, such as Candida albicans and
Candida parapsilosis, will be investigated.
The factors that determine the activity of any antimicrobial peptide are the helicity, amphipathicity,
hydrophobicity, and charge [39–42]. These parameters are strongly interrelated, which makes
predictions based on the amino acid sequence of the peptide antimicrobial activity and mode of action
difficult. Studies with model α-helical peptides have shown that to exert activity against Gram-positive
bacteria, the peptides need to adopt stabilized amphipathic conformation, while that is not always
needed in the case of Gram-negative bacteria [39]. Similarly, it has been demonstrated that the more
amphipathic a peptide is, the more hemolytic it becomes for human erythrocytes [43]. As is the case for
the vast majority of frog skin antimicrobial peptides, the ocellatins from L. insularum and L. nesiotus are
cationic (charge at pH 7 between +1 and +3). In particular, ocellatin-3N has an overall cationic charge of
+2, which could facilitate electrostatic interactions with the negatively charged bacterial cell membranes.
Two regions of helicity were predicted for this peptide between amino acid residues 4–11 and 13–18
(Table 1). A Schiffer and Edmundson [44] wheel projectionof ocellatin-3N (Figure 6) demonstrated that
the amphipathicity of the α-helix is high, with the polar Asp4, Lys7, and Lys11 residues aligning on
one face of the helix and the hydrophobic Ile2, Leu6, Leu9, Val13, and Leu17 residues aligning on the
opposite face. In addition, ocellatin-3N was the most hydrophobic of peptides tested in this study,
with a GRAVY value of 0.911. It is suggested, therefore, that the observed potency of ocellatin-3N
against Gram-positive bacteria and the hemolytic activity are a consequence of the combination of
a high degree of amphipathicity and hydrophobicity of the peptide. Although ocellatin-1N is even
more cationic than ocellatin-3N, its hydrophobicity is low. Similarly, Figure 6 demonstrates that the
amphipathicities of ocellatin-1I and -2I are low, which accounts for the weak antimicrobial activity of
these three peptides.
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e er, the clinical utility of antimicrobial peptides is limited by their short half-life in circulatio
and their toxicities against human cells. Several strategies have been employed to increase the stability
of HDPs, including the substitution of amino acid residues by D-isomers and unnatur l ami o acids;
modification of the peptide termini; dimerization and multimerization of the peptide; cyclization;
conjugation with polymers, sugars, and albumin; and the use of peptidas inhibitors [46]. Similarly, the
cationicity, hydrophobicity, and amphipathicity of HDPs may be selectively manipulated to increase
their antimicrobial potency, while simultaneously reducing their cytotoxicity to mammalian cells [41].
Moreover, the use of suitable carriers and optimized delivery systems, such as inorganic materials,
polymers, and self-assembly lipid-based and nanomaterial-based structures, has been reported for
both the systemic and local application of AMPs (reviewed in [47,48]). Such approaches would
be expected to increase AMP stability, controlled release, and reduced toxicity and simultaneously
minimize the potential side effects and/or overcome undesired host immune responses, thus alleviating
many of the challenges that AMPs face as therapeutic agents. In this light, we propose future
structure–activity studies that will involve the synthesis of long-acting analogs of ocellatin-3N
with increased broad-spectrum activity against multidrug-resistant clinical isolates of pathogenic
microorganisms and the ability to inhibit biofilm formation.
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4. Materials and Methods
4.1. Collection of Skin Secretions
Relevant permits approving the collection and sampling of live animals were granted by the
Wildlife Section, Forestry Division, Trinidad (Special Game License with nationwide validity was
issued on 21 June 2016) and by the University of the West Indies (UWI) Campus Ethics Committee
(CEC234/07/16). Adult and sub-adult L. insularum frogs (n = 9; SVL 55–85 mm; weight 13.7–74.9 g;
sex not determined) and sub-adult specimens of L. nesiotus (n = 7; SVL 21–28 mm; weight 1.1–1.9 g;
sex not determined) were collected at 10◦4′49” N, 61◦53′25” W in Cedros (Icacos, Trinidad) in May
2019. Species identification was based on audible calls and visual characteristics [35]. The animals
were taken to a nearby base for the collection of skin secretions, which was carried out by authorized
investigators. The L. insularum frogs were injected via the dorsal lymph sac with norepinephrine
hydrochloride (NE; 40 nmol/g body weight), as previously described [49]. The much smaller L. nesiotus
frogs were immersed in distilled water (130 mL) containing 40 nmol/g body weight NE for 15 min,
as described [49]. The collection solutions were acidified by the addition of concentrated hydrochloric
acid (final concentration 1%, v/v) and immediately frozen for transfer to Ulster University. The frogs
were monitored closely over a period of a few hours for any signs of distress and were subsequently
released unharmed at the site of collection.
4.2. Purification of the Peptides
The solutions containing the secretions from each animal were pooled separately and concentrated
by passage at a flow rate of approximately 2 mL/min through nine (L. insularum) and three (L. nesiotus)
Sep-Pak C-18 cartridges (Waters Associates, Milford, MA, USA) connected in series. Bound material
was eluted with acetonitrile/water/trifluoroacetic acid (TFA) (70.0:29.9:0.1, v/v/v) and freeze-dried.
The material was redissolved in 0.1% (v/v) TFA/water (2 mL) and injected onto a semipreparative
(1.0 cm × 25 cm) Vydac 218TP510 (C-18) reversed-phase HPLC column (Grace, Deerfield, IL, USA)
equilibrated with 0.1% (v/v) TFA/water at a flow rate of 2 mL/min. The following linear gradients were
used to elute the peptides: 0% to 21% (v/v) acetonitrile over 10 min, followed by 21% to 63% (v/v) over
60 min. Absorbance was monitored at 214 nm and fractions (1 min) were collected using a BioRad
2110 fraction collector.
The peaks designated 1–5 in Figure 1 and 1–4 in Figure 2 were shown to contain components with
molecular masses in the range of 1–4 kDa by MALDI-TOF mass spectrometry. These peptides were
purified to near homogeneity by successive chromatographies on (1.0 cm × 25 cm) Vydac 214TP510
(C-4), (1.0 cm × 25 cm) Vydac 219TP510 (dimethylphenyl), and (1.0 cm × 25 cm) Vydac 208TP510
(C-8) columns. For the more hydrophilic peptides (retention times < 35 min), the concentration of
acetonitrile in the eluting solvent was raised from 14% to 42% (v/v) over 50 min and for the more
hydrophobic peptides, from 21% to 56% (v/v) over 50 min. The flow rate was 2 mL/min.
4.3. Structural Characterization
The monoisotopic molecular masses of the purified ocellatins were determined by MALDI-TOF
mass spectrometry using an UltrafleXtreme instrument (Bruker Daltonik, Bremen, Germany).
Full details of the procedure, including calibration of the instrument with peptides of a known
molecular mass in the 1–4 kDa range, have been provided [50,51]. The accuracy of mass determinations
was <0.02%. The primary structures of the purified peptides were determined by automated Edman
degradation using an Applied Biosystems model 494 Procise sequenator (Foster City, CA, USA).
4.4. Synthetic Peptides
The four ocellatin peptides used in this study for an evaluation of antimicrobial and hemolytic
activities were supplied in crude form by EZBiolab Inc. (Carmel, IN, USA). The peptides were
purified by reversed-phase HPLC on a (2.2 cm × 25 cm) Vydac 218TP1022 (C-18) column equilibrated
Antibiotics 2020, 9, 718 11 of 15
with acetonitrile/water/TFA (35.0/64.9.9/0.1, v/v/v) at a flow rate of 6 mL/min. The concentration of
acetonitrile was raised to 63% (v/v) over 60 min using a linear gradient. Absorbance was measured at
214 nm and the major peak in the chromatogram was collected by hand. The identities of the peptides
were confirmed by electrospray mass spectrometry and their final purities were estimated to be >98%.
4.5. Antimicrobial Assays
Minimum inhibitory concentrations (MICs) were determined in duplicate by a standard double
dilution method according to CSLI guidelines [52] using 96-well microtiter cell-culture plates, as
previously described [49]. All reference strain bacteria, including S. aureus (ATCC 12600), E. faecium
(ATCC 19434), E. faecalis (ATCC 51299), E. coli (ATCC 35218), K. pneumoniae (ATCC 49472), P. aeruginosa
(ATCC 27853), and S. typhimurium (ATCC 14028), as well as S. aureus (ATCC BAA-2312) and
antibiotic-resistant K. pneumoniae (ATCC BAA-2814), were obtained from the Microbiology Research
Group at the Department of Life Sciences (DLS), Faculty of Science and Technology (FST), University
of the West Indies. Control incubations were carried out in parallel with increasing concentrations of
antibiotics (ampicillin for S. aureus, E. faecalis, and E. coli; vancomycin for S. aureus (ATCC BAA-2312);
and ciprofloxacin for the sensitive K. pneumoniae strain, P. aeruginosa, and S. typhimurium), in order to
monitor the validity and reproducibility of the assays. The published antibiotic sensitivity/resistance
profiles for all bacterial strains were confirmed in the authors’ laboratory prior to setting up the
MIC experiments.
4.6. Hemolysis Assay
All procedures involving mice were approved by Ulster University (UU) Animal Ethics Review
Committee and were carried out in accordance with the UK Animals (Scientific Procedures) Act 1986
and EU Directive 2010/63EU for animal experiments. Hemolytic activity against erythrocytes from NIH
Swiss female mice was determined as previously described [22]. Control incubations were carried out
in parallel in Krebs Ringer Bicarbonate buffer only or with 1% v/v Triton-X100, in order to determine
the absorbance associated with 0% and 100% hemolysis, respectively. The LC50 value was taken as the
mean concentration of peptide producing 50% hemolysis in three independent experiments.
4.7. Cladistic Analysis
The optimum phylogenetic tree was constructed using the neighbor-joining method [53].
The evolutionary distances were computed using the Poisson correction method [54] and are given as
the number of amino acid substitutions per site. All positions containing alignment gaps and missing
amino acid residues were only eliminated in pairwise sequence comparisons (pairwise deletion option).
Phylogenetic analyses were conducted in MEGA X [55].
5. Conclusions
In contrast to the majority of previously isolated ocellatin-related peptides with well-documented
weak antimicrobial activity towards Gram-negative bacteria only, ocellatin-3N from skin secretions of
the Caribbean frog L. nesiotus displays broad spectrum activity against a range of Gram-negative and
Gram-positive bacteria, including antibiotic-resistant strains. Consequently, this peptide could
serve as a template for development into an antimicrobial agent with an improved potency
and reduced cytotoxicity for red blood cells. In addition, this study has contributed to our
understanding of amphibian biodiversity in Trinidad and the primary structures of the newly
characterized ocellatin-related peptides provide insight into the phylogenetic relationships amongst
Leptodactylid frogs.
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